%PDF-1.3
%
5 0 obj
<>>>/BBox[0 0 612 792]/Length 53>>stream
xs
w3T0WI2P0T5T R
Ɩf
!\!Y\ !p
o
endstream
endobj
3 0 obj
<>>>/BBox[0 0 612 792]/Length 53>>stream
xs
w3T0WI2P0T5T R
Ɩf
!\!Y\ !p
o
endstream
endobj
4 0 obj
<>>>/BBox[0 0 612 792]/Length 53>>stream
xs
w3T0WI2P0T5T R
Ɩf
!\!Y\ !p
o
endstream
endobj
6 0 obj
<>>>/BBox[0 0 612 792]/Length 53>>stream
xs
w3T0WI2P0T5T R
Ɩf
!\!Y\ !p
o
endstream
endobj
1 0 obj
<>>>/BBox[0 0 612 792]/Length 53>>stream
xs
w3T0WI2P0T5T R
Ɩf
!\!Y\ !p
o
endstream
endobj
8 0 obj
<>stream
application/pdf
DIA-2018-0060-ver9-Stewart_3P 501..505
2018-06-26T00:04:51+05:30
Arbortext Advanced Print Publisher 9.0.114/W
2021-01-15T06:52:01-08:00
Acrobat Distiller 8.1.0 (Windows); modified using iText 4.2.0 by 1T3XT
uuid:73af3d3d-5dd2-4e48-98df-edf2abfbb301
uuid:9683e2d8-81af-4060-ac3b-7d49d7eb0295
endstream
endobj
9 0 obj
<>stream
x+ |
endstream
endobj
10 0 obj
<>stream
xS**T0T0 Bi yS&
endstream
endobj
11 0 obj
<>stream
x+ |
endstream
endobj
12 0 obj
<>stream
xS**T0T0 Bi y\'
endstream
endobj
13 0 obj
<>stream
x+ |
endstream
endobj
14 0 obj
<>stream
xS**T0T0 Bi yA$
endstream
endobj
15 0 obj
<>stream
x+ |
endstream
endobj
16 0 obj
<>stream
xS**T0T0 Bi yJ%
endstream
endobj
17 0 obj
<>stream
x+ |
endstream
endobj
18 0 obj
<>stream
xS**T0T0 Bi y8#
endstream
endobj
20 0 obj
<>stream
/GS1 gs
BT
/F5 1 Tf
9.843 0 0 9.843 72 725.1588 Tm
0 0 0 rg
-.022 Tc
0 Tw
[(The)-513.8(c)-1.2(hang)-5.8(es)-512.5(in)-512.7(cortiso)-5.8(l)-.2(,)-509.2(i)-.2(ncreased)-512.7(glucose)-513.8(u)-.1(tilization)-512.7(b)-.1(y)]TJ
-1.0137 -1.1174 TD
-.0213 Tc
[(uterine)-173.3(a)-.5(nd)-172.1(skeletal)-178(m)5.2(u).6(scles,)-168.7(and)-172.1(t).5(he)-173.3(dramatic)-173.3(decrease)-173.3(i)-5.2(n)-172.1(i).5(nsulin)]TJ
0 -1.1116 TD
-.0214 Tc
[(resistance)-196.4(immediately)-195.3(a)-.6(fter)-195.3(delivery)-195.3(m)-.7(ake)-196.4(tight)-195.4(control)-195.4(d).5(ifcult)]TJ
T*
[(to)-304.7(achieve.)]TJ
7.3823 0 0 6.5614 103.2378 696.6423 Tm
0 Tc
(6)Tj
9.843 0 0 9.843 109.7007 692.277 Tm
-.0215 Tc
[(Even)-299.1(with)-304.8(the)-300.2(r).5(ecommended)-304.8(hourly)-299.1(capillary)-304.8(glu-)]TJ
-4.8439 -1.1116 TD
-.022 Tc
[(cose)-600.2(monitoring,)-601.4(hypo-)-599(and)-599.1(hyperglycemic)-600.2(ex)-5.8(cur)-5.8(s).1(ions)-598.9(are)]TJ
0 -1.1174 TD
-.0217 Tc
[(common)-270.5(a)-.9(nd)-270.5(frequent)-270.6(insulin)-270.5(dose)-271.6(a)-.9(djustments)-270.3(are)-265.9(r).3(equir)-5.5(e)-.9(d.)]TJ
7.3823 0 0 6.5614 290.8912 674.7021 Tm
-.0239 Tc
[(4,)11.1(7)]TJ
9.843 0 0 9.843 72 659.3951 Tm
0 Tc
[(Variable)-526(rate)-519.4(intravenous)-527.1(insulin)-520.5(infusion)-521.5(\(VRIII\))-522.1(and)]TJ
-1.0137 -1.1116 TD
[(continuous)-219.6(subcutaneous)-223.8(insulin)-221(infusion)-222(\(CSII\))-220.5(are)-218.7(the)-217.7(most)]TJ
0 -1.1174 TD
[(commonly)-323.6(used)-322.2(modes)-324.5(of)-318.9(insulin)-324.7(delivery)-322.4(during)-323.5(labor)-323.5(and)]TJ
0 -1.1116 TD
.0123 Tc
[(deli)5.3(very.)-411.6(Wo)5.4(men)-415(o)-.3(n)-415(m)4.2(ul)5.3(ti)5.3(pl)5.3(e)-416.2(d)-.3(ai)5.3(ly)-415(i)5.3(n)-.3(j)5.3(e)-1.5(ctio)5.4(ns)-414.8(\()-80.9(M)4.5(DI\))-415(a)4.3(re)]TJ
T*
.0112 Tc
[(generally)-537.1(tr)4.4(eated)-542.8(w)]TJ
8.4495 0 TD
.0121 Tc
[(ith)-536.2(VRII)5.3(I.)-538.5(Thos)5.4(e)-543.1(o)5.2(n)-541.9(C)4.2(SI)5.3(I)-541.9(a)4.1(re)-543.1(o)5.2(f)-.5(t)5.1(e)-1.7(n)]TJ
-8.4495 -1.1174 TD
[(tr)5.3(an)5.2(sit)5.1(i)-.6(o)5.2(n)-.5(ed)-328.8(to)-328.8(VRI)5.3(I)-.5(I)5.3(,)-331.1(h)5.2(o)-.5(wever,)-325.4(if)-328.8(women)-323.1(a)-1.7(re)-324.2(co)5.2(mf)5.3(ort)5.1(ab)5.2(le)]TJ
0 -1.1116 TD
.0072 Tc
[(s)-5.2(e)-.8(l)-5.5(f).4(-)-5.4(m)-.9(a)-6.6(n)-5.4(ag)-5.4(in)-5.4(g)-356.8(t)-5.5(he)-6.6(ir)-356.7(C)-6.4(S)-5.3(II)-356.7(a)-6.6(n).3(d)-362.5(c)-.8(a)-6.6(n)-356.8(ma)-6.6(in)-5.4(ta)-6.6(i)-5.5(n)-356.8(th)-5.4(e)-357.9(t)-5.5(ar)-5.4(ge)-6.6(t)-356.9(g)-5.4(lu)-5.4(-)]TJ
T*
.0131 Tc
[(co)6.2(se)-507.5(c)5.1(o).5(n)6.2(cen)6.2(tr)6.3(at)6.1(io)6.2(n,)-508.7(i)6.1(n).5(s)6.4(u).5(li)6.1(n)-506.4(p).5(u)6.2(m)-.7(p)-506.4(t)6.1(he)5.1(rap)6.2(y)-506.4(ca)5.1(n)-506.4(b).5(e)-507.5(s).7(a)5.1(f).5(e)5.1(l).4(y)]TJ
T*
[(co)6.2(nt)6.1(in)6.2(ued)6.2(.)]TJ
7.3823 0 0 6.5614 104.4283 576.1132 Tm
.0147 Tc
(4,5,7)Tj
9.843 0 0 9.843 122.0598 571.7479 Tm
.0124 Tc
[(S)5.7(e)-1.4(l)5.4(f-man)5.5(ag)5.5(emen)5.5(t)-236.5(u)5.5(si)5.4(ng)-230.6(CS)5.7(II)-236.3(i)5.4(s)-236.2(l)5.4(e)-1.4(s)5.7(s)-236.2(i)5.4(nvasi)5.4(ve)]TJ
-6.0995 -1.1174 TD
.0123 Tc
[(an)5.4(d)-248(m)-1.5(ay)-253.7(p)5.4(r)-.3(o)5.4(v)-.3(id)5.4(e)-249.1(b)-.3(et)5.3(ter)-253.7(g)5.4(ly)5.4(cemi)5.3(c)-254.9(c)4.3(on)5.4(tr)5.5(ol)-248.1(th)5.4(an)-248(VRIII)-248(d)5.4(uri)5.3(ng)]TJ
0 -1.1116 TD
[(th)5.3(is)-276.7(peri)5.2(od)5.3(.)]TJ
7.3823 0 0 6.5614 107.8299 554.1731 Tm
0 Tc
(7)Tj
9.843 0 0 9.843 72 538.866 Tm
[(Furthermore,)-232.1(some)-225.5(women)-227.6(report)-232.5(feeling)-229.1(vulnerable)-227.8(when)]TJ
-1.0137 -1.1174 TD
[(the)-332.9(ability)-337.7(to)-330.6(control)-337.4(their)-335.2(own)-332.5(glucose)-338.3(is)-330.4(taken)-336.3(away)-335.9(from)]TJ
0 -1.1116 TD
[(them)-323.7(and)-327(is)-318.9(instead)-326.9()50.8(in)-325.9(the)-321.4(hands)50()-323.6(o)0(f)-324.7(less)-322.1(experienced)-329.1(ob-)]TJ
T*
[(stetric)-269.4(ward)-265.6(staff.)]TJ
7.3823 0 0 6.5614 131.1307 510.3495 Tm
(8)Tj
9.843 0 0 9.843 137.4236 505.9841 Tm
[(For)-262.3(women)-268(who)-263.4(continue)-264.8(managing)-265.9(their)]TJ
-7.6604 -1.1174 TD
[(own)-274.9(insulin)-278.6(delivery,)-279.7(the)-275.3(burden)-278.4(of)-278.6(frequent)-276.2(monitoring)-277.6(and)]TJ
0 -1.1116 TD
[(insulin)-284.4(dose)-281.8(adjustments)-280.6(can)-282.1(be)-279.8(stressful.)]TJ
7.3823 0 0 6.5614 226.2614 488.4093 Tm
(9)Tj
9.843 0 0 9.843 72 473.1022 Tm
[(A)-410.9(hybrid)-404.1(closed-loop)-417.7(system)-406.2(uses)-414.1(a)-411.2(continuous)-409.7(glucose)]TJ
-1.0137 -1.1174 TD
[(monitor)-400.8(\(CGM\),)-403.4(CSII,)-400.3(and)-401.9(computer)-404.1(algorithm)-404.3(to)-399.7(provide)]TJ
0 -1.1116 TD
[(automated)-648.5(glucose-responsive)-646.2(insulin)-641.5(delivery.)-642.6(In)-641.5(preg-)]TJ
T*
[(nancy,)-241.7(it)-244.4(has)-240.4(been)-248.6(shown)-242.3(to)-238.5(improve)-246.4(overnight)-241.7(time)-243.2(in)-244.2(target)]TJ
T*
[(and)-361.6(safely)-365.9(maintain)-364.1(effective)-360.3(glucos)-7.7(e)-359.4(control)-360.4(with)-362.6(less)-362.4(hy-)]TJ
0 -1.1174 TD
[(poglycemia)-367.3(compared)-359.1(with)-362.6(sensor-augmented)-368.8(pump)-357(\(SAP\))]TJ
0 -1.1116 TD
(therapy.)Tj
7.3823 0 0 6.5614 94.1102 411.7038 Tm
[(10,1)-8.6(1)]TJ
9.843 0 0 9.843 112.5354 407.3385 Tm
[(Its)-181.8(automated)-187.7(nature)-181.8(with)-184.1(minimal)-178.8(obstetric)-185.2(staff)]TJ
-5.1319 -1.1116 TD
[(and)-448(user)-443.1(input)-443.5(makes)-446.6(it)-446(well)-444.4(suited)-445.6(for)-446.7(use)-442(during)-444.4(labor,)]TJ
0 -1.1174 TD
[(delivery,)-285.5(and)-280.9(the)-281.1(immediate)-281.2(postpartum)-284.1(period.)]TJ
1.0137 -1.1116 TD
[(Two)-333.7(randomized)-338.4(crossover)-340.1(trials)-336.2(of)-336.2(home)-335.1(closed)-337.2(loop)-332.8(in)]TJ
-1.0137 -1.1116 TD
[(pregnancy)-318.6(have)-317.8(been)-317.8(performed.)-322.1(The)-316.7(rst)-320.9(examined)-318.9(the)-315.6(ef-)]TJ
0 -1.1174 TD
[(cacy)-538.7(of)-532.1(overnight)-535.4(closed)-533(loop)-534.4(and)-528.6(demonstrated)-542.1(better)]TJ
0 -1.1116 TD
[(glucose)-355.6(control)-354.7(overnight)-356.9(when)-352(compared)-353.3(with)-356.9(SAP)-355.2(thera-)]TJ
T*
(py.)Tj
7.3823 0 0 6.5614 74.3244 334.9983 Tm
(10)Tj
9.843 0 0 9.843 84.4157 330.633 Tm
[(The)-276.4(second)-273.7(trial)-272(examined)-278.6(day)-275.2(and)-269.4(night)-276.5(use)-275(of)-272.9(closed)]TJ
-2.2751 -1.1116 TD
[(loop)-453.8(in)-451.6(pregnancy)-462.6(and)-453.7(found)-454.7(comparable)-454.7(glucose)-459.2(control)]TJ
0 -1.1174 TD
[(measured)-405(by)-405.4(time)-404.5(in)-399.7(target)-406.6(with)-403(less)-402.7(hypoglycemia.)]TJ
7.3823 0 0 6.5614 276.0377 313.0582 Tm
(11)Tj
9.843 0 0 9.843 287.3763 308.6928 Tm
(We)Tj
-22.8948 -1.1116 TD
[(report)-428.3(on)-428.4(data)-433.1(collected)-435.4(from)-426(these)-434(randomized)-430.5(crossover)]TJ
T*
[(trials)-284.4(examining)-284.4(in)-278.8(pregnancy.)]TJ
7.3823 0 0 6.5614 183.118 291.1747 Tm
(10,11)Tj
9.843 0 0 9.843 72 275.8109 Tm
[(The)-426.1(aim)-426.3(of)-428.4(this)-424.9(study)-425.9(is)-428.4(to)-422.8(evaluate)-434.2(the)-425(feasibility)-429.6(and)]TJ
-1.0137 -1.1116 TD
[(safety)-509.9(of)-509(closed)-510(loop)-505.6(for)-510.1(maintaining)-511.5(glucose)-511.1(control)-510.2(in)]TJ
T*
[(women)-296.8(with)-287.8(T1D)-293.4(during)-294.7(labor,)-292.4(delivery,)-297(and)-292.4(the)-292.6(immediate)]TJ
0 -1.1174 TD
[(postpartum)-284.1(period.)]TJ
/F4 1 Tf
8.9663 0 0 8.9663 62.022 220.9322 Tm
(Methods)Tj
/F11 1 Tf
0 -1.8336 TD
(Participants)Tj
/F5 1 Tf
9.843 0 0 9.843 72 188.0503 Tm
[(Both)-397.2(trials)-393.8(recruited)-399.5(pregnant)-402.9(women)-394.7(18)-393.9(to)-399.7(45)-393.9(years)-399.3(of)]TJ
-1.0137 -1.1116 TD
[(age)-310.9(with)-316.6(T1D)-310.6(duration)-309.7(of)-313.2(at)-308.8(least)-313.2(12)-313.2(months)-313(and)-309.7(HbA1c)-313.7(of)]TJ
T*
[(6.5%10%)-341.6(\(4886)-167.9(mmol/mol\).)-339.9(Wo)18.6(m)15(e)0(n)-314.4(w)0(e)18.8(r)0(e)-314.4(r)0(a)19.7(n)16.2(do)20.8(m)15(i)0(z)19.6(e)15(d)-329.4(t)0(o)]TJ
T*
[(4)-220(w)0(e)24.6(e)0(k)19.7(s)-219.8(o)16.2(f)-219.9(cl)25.3(os)21(ed)-205(lo)20.7(op)-203.8(an)19.7(d)-220(4)-214.2(we)18.8(e)15(k)0(s)-209.4(o)0(f)-203.8(S)0(A)20.1(P)-219.8(t)16.1(h)0(e)19.7(r)0(a)25.5(p)0(y)20.8(,)-216.5(se)19.9(p)16.2(a)0(r)19.7(a)15(te)19.6(d)]TJ
0 -1.1174 TD
[(by)-313.2(a)-330.6(1)0()26.6(2)0(-)20.9(w)0(e)24.6(e)0(k)-320.1(w)15.3(as)19.9(ho)26.6(ut)-319.1(p)16.2(e)0(r)19.7(i)16.1(od)20.8(.)-326(A)0(f)20(t)16.1(er)-320.1(c)15(o)0(m)19.6(p)16.2(le)19.6(t)16.1(i)0(n)20.7(g)-329.4(b)16.2(o)0(t)20.7(h)-323.6(ar)19.7(m)15(s)0(,)]TJ
0 -1.1116 TD
[(wo)20(m)15(e)0(n)-452.6(c)0(o)25.4(u)0(l)20.7(d)-461.9(ch)25.4(oo)20.8(se)-452.4(to)-451.6(co)25.4(nt)20.7(i)16.1(n)0(u)20.8(e)-463(us)21(i)16.1(n)0(g)-451.5(S)0(A)20.1(P)0(,)-447.9(c)0(l)19.5(o)0(s)26.8(e)0(d)-452.6(l)0(o)20.7(o)16.2(p,)]TJ
T*
[(or)-255.6(th)20.7(e)15(i)0(r)-261.5(p)16.2(re)19.7(f)16.2(e)0(r)19.7(r)0(e)25.5(d)-271.8(C)15.2(G)0(M)19.1(/)16.1(CS)20(II)26.7(/M)19.8(D)15.3(I)-271.8(co)25.4(mb)19.6(i)16.1(n)0(a)19.7(t)16.1(io)20.7(n.)-258(W)13.9(o)0(m)25.4(e)0(n)-256.8(w)0(h)20(o)]TJ
0 -1.1174 TD
[(us)21(e)15(d)-260.3(c)15(l)0(o)20.7(s)16.4(ed)-245.3(lo)20.7(op)-244.1(fo)26.6(r)-260.3(l)16.1(ab)19.7(o)16.2(r)-260.3(a)15(n)0(d)-244.1(d)0(e)19.7(l)16.1(iv)20.7(er)25.5(y)-260.3(c)15(ou)20.8(l)16.1(d)-260.3(c)15(o)0(n)20.8(t)0(i)26.3(n)0(u)20.8(e)-255.7(it)-244.4(un)26.6(ti)20.6(l)]TJ
0 -1.1116 TD
[(th)20.7(e)15(i)0(r)-313.3(d)16.2(is)20.9(ch)25.4(ar)19.7(g)16.2(e)-324.8(fr)20.9(o)16.2(m)-324.9(h)16.2(o)0(s)21(p)0(i)26.5(t)0(a)19.6(l)-318(du)20.8(ri)26.5(ng)-313.2(t)16.1(h)0(e)-314.4(o)16.2(ve)19.7(rn)26.6(ig)20.7(h)16.2(t)-323.8(st)20.9(u)16.2(d)0(y)]TJ
7.3823 0 0 6.5614 282.6141 104.7685 Tm
-.0162 Tc
(10)Tj
9.843 0 0 9.843 293.0456 100.4031 Tm
0 Tc
(or)Tj
-23.4708 -1.1116 TD
[(fo)20.9(r)-266(u)0(p)-255.6(t)0(o)-255.8(6)-266(we)18.8(e)15(k)0(s)-261.2(p)16.2(os)21(tp)26.5(ar)19.7(t)16.1(u)0(m)-256.8(i)0(n)-255.8(t)0(h)20.7(e)-267.2(da)25.4(y-)20.9(an)25.4(d-)20.9(ni)26.5(gh)20.8(t)-266.2(s)0(t)20.9(u)16.2(dy)20.8(.)]TJ
7.3823 0 0 6.5614 283.1243 93.8268 Tm
-.0162 Tc
(11)Tj
9.843 0 0 9.843 72 78.463 Tm
0 Tc
[(The)-506.8(trial)-508.1(protocols)-512.2(were)-508.7(approved)-512.2(by)-503.3(Regional)-513.5(Ethics)]TJ
-1.0137 -1.1116 TD
[(Committees.)-556.1(As)-544.3(both)-551.7(protocols)-546.8(allowed)-552.6(for)-550.4(use)-551.4(of)-543.6(data)]TJ
T*
[(throughout)-282(pregnancy,)-281.8(no)-284.4(separate)-284.1(consent)-280.7(was)-281.6(required.)]TJ
/F11 1 Tf
8.9663 0 0 8.9663 313.0582 725.7825 Tm
[(Study)-338.6(design)]TJ
/F5 1 Tf
9.843 0 0 9.843 323.0361 709.3416 Tm
[(This)-270.5(was)-264.3(an)-268.3(observational)-271.4(study)-264.6(of)-267.1(all)-269.7(women)-268(included)-264.8(in)]TJ
-1.0137 -1.1116 TD
[(the)-188.9(trials)-180.7(described)-186.1(who)-182.7(chose)-186.2(to)-180.9(use)-182.8(closed)-187.4(loop)-183.1(during)-179.5(labor,)]TJ
0 -1.1174 TD
[(delivery,)-285.5(and)-280.9(the)-281.1(immediate)-287(postpartum)-284.1(period.)]TJ
1.0137 -1.1116 TD
[()50.8(Labor)47.6()-214.2(was)-212.5(dened)-210.4(as)-216.3(the)-211.9(24)-163.5(h)-208.4(prior)-212.9(to)-209.7(delivery)-218.7(and)-211.8()50.8(the)]TJ
-1.0137 -1.1116 TD
[(immediate)-471.3(postpartum)-462.7(period)48.7()-461.8(a)0(s)-463.9(the)-465.4(48)-169.2(h)-461.9(after)-462.9(delivery.)]TJ
0 -1.1174 TD
[(Glucose)-195.2(control)-187.7(was)-189.4(measured)-191.9(by)-186.5(CGM)-190.4(\(FreeStyle)-192.9(Navigator)]TJ
0 -1.1116 TD
[(2;)-209.7(Abbott)-209.3(Diabetes)-209.1(Care,)-212.8(Alameda,)-212.7(CA\),)-204.4(insulin)-209.5(delivery)-213(was)]TJ
T*
[(throug)-6.7(h)-381.2(a)-382.4(DANA-R)-391.2(pump)-380(\(Diabecare,)-389.8(Sooil,)-389.2(Seoul,)-384.5(South)]TJ
T*
[(Korea\))-315(and)-309.7(the)-309.9(closed-loop)-308.2(systems)-314.9(used)-310.6(were)-307.1(the)-309.9(Florence)]TJ
0 -1.1174 TD
[(D2W)-484.5(and)-476.8(Florence)-478.8(D2A)-483.1(\(both)-477.9(University)-479.8(of)-474.5(Cambridge,)]TJ
0 -1.1116 TD
[(Camb)-7.8(ridge,)-309.7(UK\).)-313.7(The)-310.9(control)-308.6(algorithm)-312.2(was)-316.2(on)-307.5(a)-313.3(tablet)-308.8(PC)]TJ
T*
[(for)-285.5(the)-281.1(former)-279.6(and)-280.9(on)-284.4(an)-279.8(Android)-279.4(phone)-283.1(for)-279.7(the)-281.1(latter.)]TJ
1.0137 -1.1174 TD
.013 Tc
[(Th)6.1(e)-513.4(g).4(lu)6.1(co)6.1(se)-513.4(ta)5(rg)6.1(et)-512.4(ra)5(ng)6.1(e)-519.2(d)]TJ
11.9341 0 TD
.0117 Tc
[(ur)4.9(ing)-513.5(p)4.8(regnancy)-513.5(w)-1.8(as)-513.3(3)4.8(.)-3.3(5)4.8()]TJ
-12.9478 -1.1116 TD
.0111 Tc
[(7.8)-168.5(mmol/)4.1(L)-210.1(\()-1.5(6)4.2(3)-1.5()4.2(1)-1.5(4)4.2(0)-168.5(mg/)4.1(d)-1.5(L\).)-211.2(T)3.1(hese)-210(t)4.1(a)-2.7(r)4.3(g)-1.5(ets)-208.7(w)-2.4(ere)-204.3(c)-2.7(hang)4.2(ed)-208.9(t)4.1(o)]TJ
T*
.0118 Tc
[(3.9)4.9(10)-162.1(mmol)4.8(/L)-485.8(\()5(7)-.8(0)4.9(18)4.9(0)-167.8(m)3.7(g/)4.8(dL\))-484.6(i)-.9(mmedi)4.8(at)4.8(el)4.8(y)-484.6(a)-2(f)5(t)-.9(er)-484.6(deliv)4.9(-)]TJ
0 -1.1174 TD
.0132 Tc
[(ery)6.3(.)-284(Th)6.3(er)6.4(e)-288.6(w)5.5(er)6.4(e)-288.6(n)6.3(o)-287.4(c)5.2(ue)5.2(s)-287.2(o)6.3(r)-287.4(c)5.2(ha)5.2(ng)6.3(es)-281.4(in)-281.6(pro)6.3(gr)6.4(am)5.1(mi)6.2(ng)-281.6(to)-281.6(an)6.3(-)]TJ
0 -1.1116 TD
.0122 Tc
[(nou)5.3(nce)-433.6(t)-.5(h)5.3(e)-439.3(o)5.3(n)-.4(s)5.5(e)-1.6(t)-432.5(o)-.4(f)-432.4(l)5.2(abo)5.3(r)-432.4(an)5.3(d/o)5.3(r)-432.4(deliv)5.3(er)5.4(y.)-434.7(Wo)5.3(men)-438.2(w)4.5(er)5.4(e)]TJ
T*
.0132 Tc
[(adm)5.1(i).5(n)6.3(i).5(s)6.5(t).5(e)5.2(r).6(ed)-275.9(pr)6.4(ep)6.3(ran)6.3(d).6(i)6.2(a)-.6(l)-276(a)-.6(n)6.3(d)-281.6(an)6.3(y)-281.6(a)5.2(dd)6.3(iti)6.2(on)6.3(al)-276(co)6.3(rre)5.2(ct)6.2(io)6.3(n)-281.6(b).6(o)6.3(-)]TJ
0 -1.1174 TD
.0125 Tc
[(lus)5.8(e)-1.3(s)-454.9(t)-.2(hr)5.7(ou)5.6(gh)-455.1(th)5.6(ei)5.5(r)-460.9(i)-.2(n)5.6(s).1(u)5.6(lin)-455.1(pu)5.6(mp)-455.1(or)-455.1(th)5.6(e)-462.1(A)4.8(nd)5.6(ro)5.6(id)-460.9(mo)5.6(bil)5.5(e)]TJ
0 -1.1116 TD
[(pho)5.6(ne)-277.7(i)5.5(f)-282.3(t)5.5(h)-.1(ey)-276.6(wer)5.7(e)-277.7(us)5.8(ing)-276.6(t)5.5(he)-277.7(Fl)5.5(or)5.7(en)5.6(ce)-277.7(D2)5.6(A)-277.5(s).1(ys)5.8(tem.)]TJ
1.0137 -1.1116 TD
0 Tc
[(Women)-194.5(were)-197.6(advised)-200(to)-192.4(change)-194.4(their)-197(insulin)-198(pump)-189.9(settings)]TJ
-1.0137 -1.1116 TD
[(and)-396.1(carbohydrate)-403.8(ratios)-393.7(as)-394.8(soon)-395.9(as)-394.8(possible)-395.7(after)-399.6(delivery,)]TJ
0 -1.1174 TD
[(with)-230.2(postnatal)-225.5(glucose)-223.1(targets)-228.9(of)-226.8(610)-165.7(mmol/L)-223.6(\(108180)-170.1(mg/)]TJ
0 -1.1116 TD
[(dL\).)-353.5(Participants)-356.7(were)-353.2(instructed)-353.3(not)-354.8(to)-347.9(bolus)-351(for)-348.8(their)-352.5(rst)]TJ
T*
[(light)-345.7(meal)-342.2(and)-344.3(only)-344.4(to)-342.1(correct)-345.3(high)-344.4(glucose)-344(concentrations,)]TJ
0 -1.1174 TD
[(dened)-285.2(as)]TJ
/F6 1 Tf
4.3428 0 TD
()Tj
/F5 1 Tf
.5529 0 TD
[(12)-169.2(mmol/L)-281.2(\(216)-165.6(mg/dL\).)]TJ
-3.882 -1.1116 TD
[(Glucose)-252.8(co)19.7(nt)20.7(ro)20.9(l)-243.1(w)0(a)18.8(s)-237.1(as)19.9(se)19.9(ss)15.5(ed)-228(by)-226.8(mo)19.6(de)-228(of)-226.8(de)19.7(li)20.6(ve)19.7(ry)-232.5(\(v)20.9(ag)19.7(in)20.7(al)]TJ
-1.0137 -1.1116 TD
[(de)13.9(li)20.6(ve)19.7(ry)20.9(,)-349(e)0(m)18.5(e)0(r)19.7(g)0(e)19.7(n)0(c)19.7(y)0(,)-338.6(o)0(r)-336.2(e)0(l)19.5(e)0(c)18.5(t)0(i)14.8(v)0(e)-337.4(c)0(e)18.5(s)0(a)19.9(r)0(e)19.7(a)0(n)-337.4(s)0(e)14.1(c)0(t)19.6(i)0(o)20.7(n)0(\))20.9(.)-349(Ma)18.8(te)19.6(rn)20.9(al)]TJ
0 -1.1174 TD
[(hy)15.1(po)20.8(gl)20.7(yc)19.7(em)18.5(ic)-314.5(ev)19.7(en)19.7(ts)-313.2(du)20.8(ri)15(ng)-313.2(in)20.7(tr)20.7(ap)19.7(ar)19.7(tu)15(m)-319.1(a)0(n)19.7(d)-323.6(po)15.1(st)20.9(pa)19.7(rt)20.7(um)-314.5(pe)19.7(-)]TJ
0 -1.1116 TD
[(ri)15(od)20.8(s)-432.9(w)0(e)18.8(r)0(e)-423.8(d)0(e)19.7()0(n)21(e)0(d)-423.8(a)0(s)-417.9(e)0(v)19.7(e)0(n)13.9(t)0(s)-416.8(l)0(a)13.8(s)0(t)20.9(i)0(n)20.7(g)]TJ
/F6 1 Tf
15.3208 0 TD
(>)Tj
/F5 1 Tf
.5414 0 TD
[(20)-146.2(mi)19.5(n)-433.1(w)0(i)19.8(t)0(h)-417(a)-434.2(CG)18.9(M)]TJ
-15.8622 -1.1116 TD
[(gl)14.9(uc)19.7(os)21(e)-186.6(o)0(f)]TJ
/F6 1 Tf
4.2046 0 TD
(<)Tj
/F5 1 Tf
.5414 0 TD
[(3.)24.3(9)-156.6(m)0(m)18.4(o)0(l)20.7(/)0(L)-182.1(\()0(7)20.9(0)-156.6(mg)19.6(/d)20.7(L\))-176.2(\(l)20.7(ev)19.7(el)-182(1\))-175(an)19.7(d)]TJ
/F6 1 Tf
14.4281 0 TD
(<)Tj
/F5 1 Tf
.5472 0 TD
[(3.)24.3(5)-156.6(m)0(m)18.4(o)0(l)20.7(/)0(L)]TJ
-19.7212 -1.1116 TD
[(\(6)15.1(3)-156.6(m)0(g)19.6(/)0(d)20.7(L)0(\))-262.6(\()0(l)20.7(e)0(v)19.7(e)0(l)-262.7(2)0(\))20.9(,)-268.4(re)19.7(sp)21(ec)18.5(ti)14.8(ve)19.7(ly)20.7(.)]TJ
/F11 1 Tf
8.9663 0 0 8.9663 313.0582 347.4708 Tm
[(Statistical)-342.4(analyses)]TJ
/F5 1 Tf
9.843 0 0 9.843 323.0361 331.0298 Tm
-.0217 Tc
[(Gl)5.9(uc)4.8(os)6.2(e)-398.3(o).2(u)6(t).1(c)4.8(o).2(m)4.8(e)-.9(s)-397(w)5.1(er)6(e)-404.1(c)4.8(al)5.9(cu)6(la)4.8(t)5.9(e)-.9(d)-397.2(w)-.6(i)5.9(t).1(h)-397.2(G)5.1(St)5.9(at)-397.3(Ve)4.8(rs)6.2(io)6(n)-402.9(2)6(.2)]TJ
-1.0137 -1.1174 TD
-.023 Tc
[(sof)4.7(t)-1.2(ware)-405.4(\(Uni)4.6(vers)4.9(it)4.6(y)-404.2(o)-1.1(f)-404.2(C)3.7(amb)4.7(r)-1(id)]TJ
12.8787 0 TD
-.0214 Tc
[(ge)5.1(\))6.3(.)-405(St)6.2(at)6.2(is)6.5(ti)6.2(ca)5.1(l)-402.8(a)-.6(n)6.3(a)-.6(l)6.2(y).5(s)6.5(e)-.6(s)-402.4(w)5.4(er)6.3(e)]TJ
-12.8787 -1.1116 TD
-.0276 Tc
[(c)-6.8(o).1(n)-5.7(d).1(u)-5.7(c)-1.1(t)-5.8(e)-1.1(d)-184.2(u)-5.7(si)-5.8(ng)-184.2(SP)-5.5(SS)-5.5(,)-180.8(R)-6.7(,)-180.8(a)-6.8(nd)-184.2(St)-5.8(at)-5.8(a)-185.4(v).1(e)-6.8(r).1(s)-5.5(i)0(o)-5.7(n)-178.5(1)-5.7(4).1(.)-8(1).1(.)-180.8(T)-6.8(he)-185.4(pe)-6.8(rc)-6.8(en)-5.7(ta)-6.8(ge)]TJ
T*
-.0232 Tc
[(of)-329.5(t)4.4(i)-1.4(me)-330.7(in)-329.6(t)4.4(a)-2.4(r)4.5(g)-1.3(et)4.4(,)-331.9(t)-1.4(i)4.4(m)3.3(e)-330.7(o)-1.3(f)-329.5(h)4.5(yp)4.5(og)4.5(ly)4.5(cemia)-330.7(a)3.3(nd)-329.6(t)4.4(i)-1.4(me)-330.7(o)4.5(f)-329.5(hy)4.5(perg)4.5(ly)4.5(-)]TJ
T*
-.0253 Tc
[(c)-4.5(e)1.2(m)-4.6(i)2.3(a)-338.6(w)1.5(ere)-332.8(s)-3.2(um)-4.6(ma)-4.5(rized)-337.4(as)-337.2(me)-4.5(an)-331.7(\(standa)-4.5(r)2.4(d)-337.4(d)2.4(e)-4.5(v)2.4(iation)-331.7([SD)-4.2(])2.4(\))-337.4(o)2.4(r)]TJ
0 -1.1174 TD
-.0275 Tc
[(m)-6.8(e)-1(d)-5.6(i).1(a)-6.7(n).2(s)-189.7(\()-5.5(in)-5.6(te)-6.7(rq)-5.6(ua)-6.7(rt)-5.7(il)-5.7(e)-185.3(r)-5.5(an)-5.6(ge)-191([)-5.5(I).2(Q)-6.4(R)-.8(])-5.5(\))-189.8(wh)-5.6(er)-5.5(e)-185.3(a)-6.7(pp)-5.6(ro)-5.6(pr)-5.5(ia)-6.7(te)-6.7(.)-186.4(S)-5.4(tu)-5.5(de)-6.7(nt)-5.7(s)]TJ
/F7 1 Tf
0 -1.1116 TD
0 Tc
(t)Tj
/F5 1 Tf
.2592 0 TD
-.0247 Tc
[(-tests)-365.4(and)-365.6(M)-3.7(annW)-5(h)3(itneyWilc)]TJ
12.4007 0 TD
-.025 Tc
[(oxon)-365.9(tests)-365.7(w)1.8(e)-4.2(r)2.7(e)-372.8(p)2.7(erformed)-371.7(as)]TJ
-12.6598 -1.1116 TD
-.0217 Tc
[(ap)6(pr)6(op)6(ri)5.9(at)5.9(e)-242.8(a)4.8(nd)-235.9(pr)6(es)6.2(en)6(ted)-241.7(w)5.1(i)5.9(t).1(h)]TJ
/F7 1 Tf
11.9399 0 TD
0 Tc
(P)Tj
/F5 1 Tf
.5933 0 TD
-.0275 Tc
[(-v)-5.6(al)-5.7(ue)-6.7(s)-241.5(a)-6.7(nd)-5.6(/o)-5.6(r)-241.7(9)-5.6(5%)-242.8(c)-6.7(o).2(n)-5.6().4(d)-5.6(e)-1(n)-5.6(c)-1(e)]TJ
-12.5331 -1.1174 TD
-.0222 Tc
[(in)5.5(terv)5.5(al)5.4(s.)-256(A)]TJ
/F7 1 Tf
4.6769 0 TD
0 Tc
(P)Tj
/F5 1 Tf
.5875 0 TD
-.0217 Tc
[(-v)6(al)5.9(ue)-254.3(of)]TJ
/F6 1 Tf
3.6632 0 TD
0 Tc
(<)Tj
/F5 1 Tf
.5299 0 TD
-.0274 Tc
[(0.0)-5.5(5)-264.6(was)-264.5(c)-6.6(on)-5.5(si)-5.6(de)-6.6(re)-6.6(d)-258.9(s)-5.3(ig)-5.5(ni)-5.6(c)-6.6(an)-5.5(t.)]TJ
/F4 1 Tf
8.9663 0 0 8.9663 313.0582 221.2157 Tm
0 Tc
(Results)Tj
/F5 1 Tf
9.843 0 0 9.843 323.0361 204.7747 Tm
[(Of)-233.4(the)-229.2(32)-232.6(women)-233.4(enrolled)-236(in)-232.7(the)-229.2(two)-234.7(closed-loop)-233.4(trials,)-230.2(27)]TJ
-1.0137 -1.1174 TD
[(\(84.4%\))-189.6(used)-189.7(closed)-193.2(loop)-183.1(during)-191(labor)-191.1(and)-183(delivery.)-193.4(They)-191.1(had)]TJ
0 -1.1116 TD
[(a)-209.6(mean)-203.8(age)-207.2(\(SD\))-206.6(of)-203.8(32.6)-202.6(\(4.6\))-209.4(years,)-206.9(diabetes)-208.2(duration)-206(of)-203.8(21.9)]TJ
T*
[(\(8.9\))-341.8(years,)-345.1(booking)-336.1(HbA1c)-342.5(7.4)-339.7(\(0.9\)%)-344(\(57.2)-341.9([10.3])-337.2(mmol/)]TJ
0 -1.1174 TD
[(mol\),)-256.8(and)-257.9(body)-257.8(mass)-254.1(index)-254.5(of)-255.6(28.3)-254.4(\(4.7\))-261.2(kg/m)]TJ
7.3823 0 0 6.5614 494.4755 165.3165 Tm
(2)Tj
9.843 0 0 9.843 498.1605 160.8945 Tm
[(.)-256.9(Five)-253.2(women)]TJ
-18.8054 -1.1116 TD
[(did)-326(not)-326(use)-326.8(closed)-325.6(loop)-327.1(during)-323.5(labor)-329.3(and)-327(delivery)-328.1(\()]TJ
/F7 1 Tf
20.9193 0 TD
(n)Tj
/F6 1 Tf
.6624 0 TD
(=)Tj
/F5 1 Tf
.72 0 TD
[(2)-323.6(for)]TJ
-22.3016 -1.1116 TD
[(overnight)-247.5(trial)-243.2(and)]TJ
/F7 1 Tf
7.6431 0 TD
(n)Tj
/F6 1 Tf
.6681 0 TD
(=)Tj
/F5 1 Tf
.7142 0 TD
[(3)-243(for)-239.4(day-and-night)-247.2(trial\).)-241.9(The)-241.8(reasons)]TJ
-9.0255 -1.1174 TD
[(for)-325.8(this)-321.3(included:)-317.9(maintainin)-9.3(g)-317.9(tight)-322.7(glucose)-321(control)-320.1(on)-319(SAP)]TJ
0 -1.1116 TD
(\()Tj
/F7 1 Tf
.3341 0 TD
(n)Tj
/F6 1 Tf
.6681 0 TD
(=)Tj
/F5 1 Tf
.72 0 TD
[(2\),)-368.5(intermittent)-374.6(use)-372.9(\()]TJ
/F7 1 Tf
8.5589 0 TD
(n)Tj
/F6 1 Tf
.6624 0 TD
(=)Tj
/F5 1 Tf
.72 0 TD
[(1\),)-368.5(delivery)-374.2(out)-372.1(of)-370.8(the)-367.5(country)]TJ
-11.6634 -1.1116 TD
(\()Tj
/F7 1 Tf
.3341 0 TD
(n)Tj
/F6 1 Tf
.6681 0 TD
(=)Tj
/F5 1 Tf
.72 0 TD
[(1\),)-282.1(and)-280.9(unknown)-279.3(\()]TJ
/F7 1 Tf
7.4243 0 TD
(n)Tj
/F6 1 Tf
.6681 0 TD
(=)Tj
/F5 1 Tf
.72 0 TD
(1\).)Tj
/F11 1 Tf
8.9663 0 0 8.9663 313.0582 83.9622 Tm
[(Anesthesia)-335.7(and)-335.7(infant)-333.4(delivery)]TJ
/F5 1 Tf
9.843 0 0 9.843 323.0361 67.5212 Tm
[(The)-305.2(closed-loop)-302.5(system)-308.2(achieved)-301.6(a)-307.5(median)-304(time)-300.8(in)-301.8(target)]TJ
-1.0137 -1.1116 TD
[(of)-232.6(84.3)-237.1(\(IQR)-230.9(74.7,)-234.8(88.8\)%,)-232.3(84.4)-231.4(\(IQR)-236.6(48.5,)-229(93.7\)%,)-232.3(and)-234.9(76.5)]TJ
/F4 1 Tf
8.9663 0 0 8.9663 62.022 749.6502 Tm
(502)Tj
46.1573 0 TD
[(STEWART)-336.7(ET)-338.7(AL.)]TJ
ET
endstream
endobj
31 0 obj
<>stream
/GS1 gs
BT
/F5 1 Tf
9.843 0 0 9.843 59.7543 531.666 Tm
0 0 0 rg
0 Tc
0 Tw
[(\(IQR)-259.7(48.2,)-257.8(93.0\)%)-257.6(for)-250.9(vaginal)-263.7(delivery,)-256.7(emergency)-257.7(cesarean)]TJ
0 -1.1116 TD
[(section,)-220.9(and)-211.8(elective)-221.2(cesarean)-216(section,)-220.9(respectively)-219.6(\(Table)-217.6(1\).)]TJ
0 -1.1174 TD
[(Participants)-224.2(also)-218.6(used)-218.5(closed)-216.2(loop)-217.6(under)-219.7(a)-215.4(variety)-217.6(of)-215.3(different)]TJ
0 -1.1116 TD
[(methods)-188.6(of)-186.5(anesthesia,)-191.8(including)-190(spinal,)-184.1(epidural,)-193.4(and)-183(general)]TJ
T*
[(anesthetic.)-243.9(Closed)-239.1(loop)-234.9(was)-235.5(used)-235.8(during)-237.1(both)-234.9(monopolar)-237(and)]TJ
T*
[(bipolar)-302.8(diathermy)-307.4(without)-297(complication.)-304.1(Monop)-6.4(olar)-299.4(and)-298.2(bi-)]TJ
0 -1.1174 TD
[(polar)-467.5(diathermy)-468.7(are)-460.6(tools)-466.3(commonly)-467.6(used)-466.1(in)-463.1(surgery,)-461.3(in-)]TJ
0 -1.1116 TD
[(cluding)-458.4(cesarean)-463.7(section,)-457(during)-456(which)-456.9(electric)-457.3(current)-459.4(is)]TJ
T*
[(used)-310.6(to)-307.6(cut)-309.9(tissues)-308.1(or)-307.4(achieve)-312(hemostasis.)-311.4(Additionally,)-307.3(one)]TJ
0 -1.1174 TD
[(participant)-350.2(underwent)-341.5(abdominal)-347.8(cystectomy)-344.1(under)-340.7(general)]TJ
0 -1.1116 TD
[(anesthetic)-413.3(following)-402.8(cesarean)-411.8(section)-407.5(under)-409.8(a)-399.7(spinal)-411(anes-)]TJ
T*
[(thetic.)-283.5(She)-280.8(maintained)-286.8(near)-283.2(normoglycemia)-285.5(throughout.)]TJ
/F11 1 Tf
8.9663 0 0 8.9663 59.7543 380.1826 Tm
[(Obstetrical)-334.6(outcomes)]TJ
/F5 1 Tf
9.843 0 0 9.843 69.7323 363.7416 Tm
[(The)-403.1(median)-396.2(gestational)-401.8(age)-403(at)-400.9(delivery)-397.3(was)-402.6(37.0)-398.4(weeks)]TJ
-1.0137 -1.1116 TD
[(\(IQR)-300(34.6,)-298.2(37.7\),)-299.2(with)-299.3(eight)-300.7(preterm)-299.3(deliveries)-302.7(\(29.6%\))-299(and)]TJ
T*
[(15)-307.5(\(55.6%\))-310.6(large-for-gestational-age)-318.2(infants.)-311.8(There)-308.5(were)-307.1(18)]TJ
0 -1.1174 TD
[(neonates)-403.9(\(66.7%\))-396.9(with)-397.2(hypoglycemia)-398.3(dened)-394.7(as)-400.6(a)-393.9(glucose)]TJ
0 -1.1116 TD
[(concentration)-399.5(of)]TJ
/F6 1 Tf
7.0844 0 TD
(<)Tj
/F5 1 Tf
.5529 0 TD
[(2.6)-166.9(mmol/L)-390.7(\(47)-164.5(mg/dL\);)-396.3(of)-388.1(these,)-391.3(15)-388.1(in-)]TJ
-7.6374 -1.1116 TD
[(fants)-323.4(\(56%\))-323.3(were)-318.6(admitted)-323.8(to)-319.1(a)-319(neonatal)-323.6(intensive)-323.5(care)-324.6(unit)]TJ
T*
[(\(NICU\).)-329.5(A)-318.7(further)-325.7(three)-324.7(infants)-325.7(were)-324.4(admitted)-323.8(to)-319.1(NICU)-323.9(for)]TJ
0 -1.1174 TD
[(treatment)-435.4(of)-434.1(sepsis)-433.5(or)-434.1(jaundice)-433(but)-435.4(did)-429.6(not)-429.7(have)-432.9(neonatal)]TJ
25.5097 24.8531 TD
[(hypoglycemia.)-603.4(Six)-602.3(women)-607.8(had)-603.5(preeclampsia,)-605.5(three)-606.9(had)]TJ
0 -1.1116 TD
[(postpartum)-289.9(hemorrhages,)-296.5(and)-286.7(one)-292.4(had)-286.7(a)-290.2(severe)-292.1(urinary)-291.2(tract)]TJ
0 -1.1174 TD
[(infection)-283.3(requiring)-282(intravenous)-285.2(antibiotics.)]TJ
/F11 1 Tf
8.9663 0 0 8.9663 310.8472 480.4156 Tm
[(Glycemic)-330.4(control)-337.9(outcomes)]TJ
/F5 1 Tf
9.843 0 0 9.843 320.8251 463.9747 Tm
[(Women)-350(who)-349.8(used)-345.2(closed)-354.4(loop)-350.1(during)-346.5(labor)-352.4(and)-350(delivery)]TJ
-1.0137 -1.1116 TD
[(were)-318.6(in)-324.9(the)-321.4(target)-320.2(glucose)-321(range)-324.6(82.0)-317.8(\(IQR)-323(49.3,)-321.2(93.0\)%)-321(of)]TJ
T*
[(time,)-229.4(with)-230.2(a)-232.7(mean)-232.6(glucose)-234.6(concentration)-232.4(of)-232.6(6.9)-230.3(\(1.4\))-232.4(mmol/L)]TJ
0 -1.1174 TD
[(\(124)-384.5([25])-390.2(mg/dL\).)-386.9(Median)-390.1(sensor)-387.5(glucose)-390.1(variability)-389.4(mea-)]TJ
0 -1.1116 TD
[(sured)-265.6(by)-261.4(SD)-262.1(was)-264.3(1.7)-259.1(\(1.2,)-263.6(2.1\))-265.9(mmol/L)-264(\(31)-262.5([22,)-260.1(38])-262.5(mg/dL\).)]TJ
T*
[(The)-454.9(time)-462.1(spent)-455.9(above)-462.9(target)-458.4(was)-460.2(16.0)-456(\(IQR)-461.3(7.1,)-452.6(46.7\)%.)]TJ
0 -1.1174 TD
[(Hypoglycemia)-301.3(was)-298.9(uncommon;)-295.9(median)-298.3(\(IQR\))-301.1(time)-295(was)-298.9(be-)]TJ
0 -1.1116 TD
[(low)-309.6(target)-314.4(0)-312.1(\(0,)-310.9(2.2\)%.)-311.8(The)-316.7(median)-309.8(\(IQR\))-318.3(number)-308.5(of)-313.2(hypo-)]TJ
T*
[(glycemic)-543.7(events)-544.5(was)-540.8(0)-542.5(\(0,)-541.3(1.0\),)-545.8(although)-540.1(seven)-543.3(women)]TJ
0 -1.1174 TD
[(\(26.9%\))-281.8(had)-280.9(at)-280(least)-284.4(1)-277.6(hypoglycemic)-283.2(event)-8(.)]TJ
1.0137 -1.1116 TD
[(In)-203.8(the)-206.2(rst)-205.7(48)-163.5(h)-208.4(postpartum,)-207(the)-206.2(mean)-203.8(glucos)-7.7(e)-203.8(was)-206.7(7.2)-201.5(\(1.4\))]TJ
-1.0137 -1.1116 TD
[(mmol/L)-269.7(\(130)-263.6([25])-269.3(mg/dL\).)-266(During)-272.5(this)-263.7(period,)-270.5(women)-268(spent)]TJ
T*
[(83.3)-461.8(\(IQR)-467(75.2,)-465.2(94.6\)%)-465(of)-468.7(the)-465.4(time-in-target)-470(range,)-466.2(with)]TJ
0 -1.1174 TD
[(minimal)-363.1(hyperglycemia)-371.8(median)-361.6(of)-365(\(IQR\))-364.4(9.1)-362.7(\(1.5,)-361.5(20.6\)%.)]TJ
0 -1.1116 TD
[(Median)-321(sensor)-324.1(glucose)-321(variability)-326.1(measured)-324.3(by)-319(SD)-319.7(was)-321.9(2.4)]TJ
T*
[(\(1.7,)-373(2.8\))-369.6(mmol/L)-373.4(\(43)-371.9([31,)-375.3(50])-371.9(mg/dL\).)-369.7(Mild)-374.2(\(level)-377.8(1\))-370.8(hy-)]TJ
0 -1.1174 TD
[(poglycemia)-540.1(was)-540.8(slightly)-539(more)-542.4(common)-534.4(postpartum)-543.3(than)]TJ
0 -1.1116 TD
[(during)-323.5(labor)-317.8(and)-327(delivery;)-323.6(median)-321.3(\(IQR\))-324.1(time)]TJ
/F6 1 Tf
19.0819 0 TD
(<)Tj
/F5 1 Tf
.5529 0 TD
[(3.9)-166.9(mmol/L)]TJ
-19.6348 -1.1116 TD
(\()Tj
/F6 1 Tf
.3341 0 TD
(<)Tj
/F5 1 Tf
.5529 0 TD
[(70)-163.5(mg/dL\))-245.3(was)-247.1(2.5)-247.5(\(0.9,)-240.5(5.8\)%.)-248.5(The)-247.6(median)-246.4(\(IQR\))-249.2(number)]TJ
-.887 -1.1174 TD
[(of)-434.1(hypoglycemic)-432.9(events)-435.1(was)-437.1(1.5)-431.9(\(1.0,)-436.4(3.0\).)-430.6(If)-434.1(a)-434.2(threshold)]TJ
0 -1.1116 TD
[(\(level)-469.9(2)-473.4(hypoglycemia\))-474.3(of)]TJ
/F6 1 Tf
11.5252 0 TD
(<)Tj
/F5 1 Tf
.5529 0 TD
[(3.5)-166.9(mmol/L)-471.3(\()]TJ
/F6 1 Tf
5.4602 0 TD
(<)Tj
/F5 1 Tf
.5529 0 TD
[(63)-163.5(mg/dL\))-475.7(was)]TJ
-18.0912 -1.1116 TD
[(used,)-342.9(women)-348.6(did)-343.3(not)-343.3(have)-346.6(any)-344.3(hypoglycemic)-346.5(events)-348.7(in)-342.2(the)]TJ
0 -1.1174 TD
[(immediate)-281.2(postpartum)-284.1(period.)]TJ
1.0137 -1.1116 TD
.0117 Tc
[(There)-313.1(w)-1.8(ere)-313.1(n)-.9(o)-311.9(i)-1(n)4.8(c)-2.1(i)4.7(d)-.9(ent)4.7(s)-317.5(of)-311.9(severe)-313.1(hy)4.8(pog)4.8(ly)4.8(cemi)4.7(a)-318.9(d)4.8(ur)4.9(in)4.8(g)]TJ
-1.0137 -1.1116 TD
.0122 Tc
[(l)5.2(a)-1.6(b)5.3(or,)-423.2(d)5.3(e)-1.6(l)5.2(i)-.5(very)5.3(,)-423.2(o)-.4(r)-426.6(t)5.2(he)-422(immedi)5.2(at)5.2(e)-427.8(p)-.4(o)5.3(s)-.2(t)5.2(p)-.4(artu)5.3(m)-427.9(p)5.3(er)5.4(iod)5.3(,)-423.2(no)5.3(r)]TJ
T*
.0116 Tc
[(wer)4.8(e)-226.8(there)-226.8(s)4.9(er)4.8(iou)4.7(s)-225.4(device-)4.8(r)-1(elated)-225.6(adv)4.7(e)-2.2(r)4.8(s)-.8(e)-226.8(e)3.6(vents)-225.4(d)4.7(ur)4.8(ing)-225.6(t)4.6(hi)4.6(s)]TJ
0 -1.1174 TD
.0076 Tc
[(ti)-5.1(me)-6.2(.)]TJ
/F11 1 Tf
8.9663 0 0 8.9663 310.8472 149.726 Tm
0 Tc
[(Neonatal)-335.2(hypoglycemia)-330.5(and)-335.7(maternal)-331.8(glucose)]TJ
0 -1.2203 TD
[(concentration)-333.3(in)-336.5(labor)]TJ
/F5 1 Tf
9.843 0 0 9.843 320.8251 122.3433 Tm
[(There)-383.4(was)-385.3(no)-382.3(difference)-390.1(in)-382.5(mean)-382.3(glucose)-384.4(in)-382.5(mothers)-390.1(of)]TJ
-1.0137 -1.1174 TD
[(infants)-677(with)-679.4(neonatal)-680.7(hypoglycemia)-680.6(and)-678.3(those)-674.7(without)]TJ
0 -1.1116 TD
[(\(mean)-371.9([SD])-367.9(maternal)-376.6(glucose)-367.1(of)-370.8(6.9)-368.5([1.6])-370.6(mmol/L)-373.4(and)-367.3(6.8)]TJ
T*
[([1.1])-606.8(mmol/L)-609.5([124)-609.1(\(29\))-609.1(and)-609.2(122)-608.1(\(20\))-609.1(mg/dL],)-605.8(respec-)]TJ
0 -1.1174 TD
(tively;)Tj
/F7 1 Tf
2.9778 0 TD
(P)Tj
/F6 1 Tf
.7833 0 TD
(=)Tj
/F5 1 Tf
.72 0 TD
[(0.84\).)-408.7(There)-412.2(was)-408.3(also)-408.7(no)-411.1(difference)-413.1(in)-411.3(the)-407.8(per-)]TJ
-4.481 -1.1116 TD
[(centage)-386.9(of)-382.3(time)-387.2(in)-382.5(target)-383.5(\()]TJ
/F7 1 Tf
11.0183 0 TD
(P)Tj
/F6 1 Tf
.7833 0 TD
(=)Tj
/F5 1 Tf
.72 0 TD
[(0.88\))-382.2(\(Fig.)-382.2(1\))-382.3(or)-388.1(time)-381.4(above)]TJ
-12.5216 -1.1116 TD
[(target)-279.9(\()]TJ
/F7 1 Tf
2.9029 0 TD
(P)Tj
/F6 1 Tf
.7833 0 TD
(=)Tj
/F5 1 Tf
.72 0 TD
(0.76\).)Tj
ET
59.754 719.49 490.167 .22668 re
f
59.754 582.406 490.167 .22681 re
f
59.754 680.882 490.167 .22681 re
f
BT
/F9 1 Tf
9.845 0 0 9.845 130.7338 725.1588 Tm
(Table)Tj
/F5 1 Tf
3.0002 0 TD
(1.)Tj
/F9 1 Tf
1.2496 0 TD
[(Glucose)-336.8(Control)-331.2(During)-337.3(Labor)-334(and)-332(Delivery)-336.8(by)-330(Mode)-332.7(of)-337(Delivery)]TJ
/F7 1 Tf
13.999 -1.8427 TD
(Vaginal)Tj
-.0345 -1.0135 TD
(delivery)Tj
/F5 1 Tf
.6795 -1.0135 TD
(n)Tj
/F6 1 Tf
.668 0 TD
(=)Tj
/F7 1 Tf
.7141 0 TD
(4)Tj
6.9678 2.027 TD
(Emergency)Tj
.4492 -1.0135 TD
(cesarean)Tj
-.9732 -1.0135 TD
(section)Tj
/F5 1 Tf
3.1787 0 TD
(n)Tj
/F6 1 Tf
.6622 0 TD
(=)Tj
/F7 1 Tf
.7198 0 TD
(12)Tj
6.2595 2.027 TD
(Elective)Tj
-.1843 -1.0135 TD
(cesarean)Tj
-.9732 -1.0135 TD
(section)Tj
/F5 1 Tf
3.1787 0 TD
(n)Tj
/F6 1 Tf
.6622 0 TD
(=)Tj
/F7 1 Tf
.7198 0 TD
(11)Tj
/F5 1 Tf
-48.153 -1.8946 TD
[(Mean)-335.4(glucose,)-335.1(mmol/L)-338(\(SD\))-12356.7(6.3)-333.6(\(0.2\))-5973.2(7.0)-333.6(\(1.5\))-6359(7.0)-327.8(\(1.6\))]TJ
0 -1.0135 TD
[(Mean)-335.4(glucose,)-335.1(mg/dL)-335.7(\(SD\))-12673.4(113)-331.2(\(3.6\))-5719.8(126)-337(\(27\))-6355.6(126)-331.2(\(29\))]TJ
0 -1.0077 TD
[(Median)-337.5(time-in-target*,)-340.5(%)-330.2(\(IQR\))-10067(84.3)-334.6(\(74.7,)-333.2(88.8\))-2639(84.4)-334.6(\(48.5,)-333.2(93.7\))-3024.8(76.5)-328.8(\(48.2,)-338.9(93.0\))]TJ
0 -1.0135 TD
[(Median)-337.5(time)-334.9(below)-335.4(target,)-334.5(%)-336(\(IQR\))-10147.6(0)-335(\(0,)-333.6(3.4\))-4889.6(0.8)-333.6(\(0,)-333.6(2.0\))-6024(0)-329.2(\(0,)-333.6(2.2\))]TJ
T*
[(Median)-337.5(time)-334.9(above)-335.5(target,)-334.5(%)-336(\(IQR\))-8949.8(15.7)-334.6(\(11.2,)-333.2(22.0\))-2639(11.4)-334.6(\(6.3,)-332.2(50.4\))-3525.8(16.5)-328.8(\(7.1,)-338(51.8\))]TJ
T*
[(Median)-337.5(sensor)-335(glucose)-337.5(SD,)-334.2(mmol/L)-332.3(\(IQR\))-6640.6(1.7)-333.6(\(1.4,)-332.2(2.0\))-4141(1.5)-333.6(\(1.2,)-332.2(2.2\))-4526.8(1.8)-327.8(\(1.1,)-338(2.2\))]TJ
0 -1.0077 TD
[(Median)-337.5(sensor)-335(glucose)-337.5(SD,)-334.2(mg/dL)-329.9(\(IQR\))-7458.3(31)-330.2(\(25,)-334.6(36\))-4886.2(27)-336(\(22,)-334.6(40\))-5272(32)-330.2(\(20,)-334.6(40\))]TJ
0 -1.0135 TD
[(Median)-337.5(number)-336.5(of)-330.2(hypoglycemic)-339.4(events)-336.5(\(IQR\))-5615.6(0)-335(\(0,)-333.6(1.0\))-5638.2(0)-335(\(0,)-333.6(1.0\))-6024(0)-329.2(\(0,)-333.6(1.0\))]TJ
T*
[(Number)-337.3(of)-336(women)-330.6(with)-339.1(a)-330.4(hypoglycemic)-339.4(event)-335.7(\(%\))-3885.2(1)-335(\(25.0\))-6221.8(3)-335(\(27.2\))]TJ
/F7 1 Tf
37.9315 0 TD
(n)Tj
/F6 1 Tf
.668 0 TD
(=)Tj
/F5 1 Tf
.7198 0 TD
[(11)-3889(3)-329.2(\(27.2\))]TJ
8.7511 0 0 8.7511 67.748 570.5574 Tm
[(*The)-336(glucose)-328.2(target)-334.7(range)-338.4(during)-327.2(labor)-336(and)-334.6(delivery)-332.4(was)-335.2(3.57.8)-161.4(mmol/L)-331.6(\(63140)-165.3(mg/dL\).)]TJ
0 -1.0236 TD
[(IQR,)-332.8(interquartile)-335.5(range;)-336(SD,)-332.8(standard)-332.1(deviation.)]TJ
ET
q
1 i
60.321 263.055 m
298.261 263.055 l
298.261 93.26 l
60.321 93.26 l
W n
q
238.023 0 0 169.795 60.321 93.26 cm
/Im1 Do
Q
Q
BT
/F8 1 Tf
9.845 0 0 9.845 59.7543 76.4787 Tm
[(FIG.)-423.1(1.)]TJ
/F5 1 Tf
4.2037 0 TD
[(Box)-418.6(plot)-418.9(of)-422.4(percentage)-424.8(of)-422.4(time)-421.3(in)-416.8(target)-423.3(during)]TJ
-4.2037 -1.0077 TD
[(labor)-276.9(and)-274.8(delivery)-275.5(for)-273.6(mothers)-274.2(of)-272.6(neonates)-276.3(with)-270(and)-274.8(without)]TJ
0 -1.0135 TD
[(neonatal)-340(hypoglycemia.)]TJ
/F4 1 Tf
8.9663 0 0 8.9663 59.7543 749.7069 Tm
[(CLOSED)-338.9(LOOP)-332.1(DURING)-340.3(LABOR)-333.3(AND)-337.2(DELIVERY)-29692.5(503)]TJ
ET
endstream
endobj
33 0 obj
<>stream
Adobe d C
b
s !1AQa"q2B#R3b$r%C4Scs5D'6Tdt&
EFVU(eufv7GWgw8HXhx)9IYiy*:JZjz ? Nl=FIn